Loading...
•
Mar 31, 2024
OptimizeRx Q1 2024 Earnings Report
OptimizeRx's Q1 2024 financial results were reported, showing revenue growth and increased gross profit.
Key Takeaways
OptimizeRx reported Q1 2024 revenue of $19.7 million, a 51% increase year-over-year. Gross profit increased by 64% to $12.2 million, with a gross margin of 62%. The company won 9 DAAP deals during the quarter and reiterated its full-year 2024 revenue guidance of at least $100 million and Adjusted EBITDA of at least $11 million.
Q1 revenue reached $19.7 million, a 51% increase year-over-year.
Gross profit increased by 64% year-over-year to $12.2 million, with a gross margin of 62%.
The company secured 9 DAAP wins in Q1.
Net Revenue Retention came in at 116% for the first quarter.
Forward Guidance
The Company is reiterating its 2024 guidance and expects revenue to be at least $100 million with an Adjusted EBITDA of at least $11 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...